CARVIDON MR TAB
₹277.50
Carvidon-MR Tablet is a modified-release formulation containing 35 mg of Trimetazidine, an anti-anginal medication used to manage stable angina pectoris (chronic chest pain due to reduced blood flow to the heart). It works by improving the heart’s energy metabolism, enhancing its efficiency and reducing the frequency of angina attacks.
Description
Composition:
-
Trimetazidine Hydrochloride 35 mg (Modified-Release)
Manufacturer: Micro Labs Ltd.
Therapeutic Class: Cardiac Drugs
Indications:
-
Symptomatic treatment of stable angina pectoris
Mechanism of Action:
Trimetazidine works by shifting the heart’s energy metabolism from fatty acids to glucose, which is more efficient under low oxygen conditions. This shift helps maintain cellular energy levels in the heart muscle, improving its function and reducing the frequency and severity of angina attacks.
Dosage and Administration:
-
Recommended Dosage: One 35 mg tablet twice daily (morning and evening) during meals.
-
Administration: Swallow the tablet whole with a glass of water; do not chew or crush.
-
Consistency: Take at the same times each day to maintain even blood levels.
Side Effects:
Common side effects may include dizziness, headache, nausea, abdominal pain, indigestion, diarrhea, rash, itching, and weakness. These are generally mild and transient.
Precautions:
-
Allergy: Avoid if allergic to Trimetazidine or any other components.
-
Parkinson’s Disease: Not recommended for use in patients with Parkinson’s disease.
-
Kidney Impairment: Use with caution in patients with renal impairment; dose adjustment may be necessary.
-
Pregnancy and Breastfeeding: Consult a healthcare provider before use during pregnancy or breastfeeding
Reviews
There are no reviews yet.